Production of antimicrobial paper using nanosilver, nanocellulose, and chitosan from a coronavirus perspective | Zendy

Mihir Patel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Production of antimicrobial paper using nanosilver, nanocellulose, and chitosan from a coronavirus perspective

Author(s) -

Mihir Patel

Publication year - 2021

Publication title -

tappi journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.217

H-Index - 45

ISSN - 0734-1415

DOI - 10.32964/tj20.7.455

Subject(s) - nanocellulose , antimicrobial , chitosan , coronavirus , nanotechnology , covid-19 , production (economics) , perspective (graphical) , business , engineering , chemistry , materials science , computer science , chemical engineering , economics , medicine , cellulose , infectious disease (medical specialty) , disease , pathology , macroeconomics , organic chemistry , artificial intelligence

The pulp and paper industry has an opportunity to play a vital role in breaking the spread of the COVID-19 pandemic through production that supports widespread use of antimicrobial paper. This paper provides a brief review of paper and paper-related industries, such as those producing relevant additives, and R&D organizations that are actively engaged in developing antimicrobial papers. The focus here is on the potential of three nano-additives for use in production of antimicrobial papers that com-bat coronavirus: nanosilver, nanocellulose, and chitosan. Various recent developments in relevant areas and concepts underlining the fight against coronavirus are also covered, as are related terms and concepts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research